# An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

> **NCT00684385** · — · APPROVED_FOR_MARKETING · sponsor: **AstraZeneca**

## Conditions studied

- Non Small Cell Lung Cancer
- Cancer of the Head and Neck

## Interventions

- **DRUG:** ZD1839

## Key facts

- **NCT ID:** NCT00684385
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684385, "An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00684385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*